XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.23.3

Share-Based Compensation & Warrants | 9 Months Ended
--- | ---
Sep. 30, 2023
Equity [Abstract] |
Share-Based Compensation & Warrants | Note 9. Share-Based Compensation & Warrants Options Generally accepted accounting principles require share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income statement based on their fair values at the date of grant, net of estimated forfeitures. The Company has granted stock-based compensation to employees, including the issuance of 1,872,918 employee stock options granted in June 2022 that were to vest over a period of two years, for which 451,158 of these options were cancelled with the resignation without cause in October 2022 of our prior Chief Executive Officer. For the nine months ended September 30, 2023 and 2022, employee stock-based compensation was $1,260,476 and $1,340,703. On October 24, 2022, the Compensation Committee resolved to increase their compensation including the issuance of 100,000 stock options per independent board member, exercisable at $2.50 per share, vesting immediately. Non-statutory or independent Board of Director stock-based compensation was none and $855,000 for the nine months ended September 30, 2023 and 2022. In 2022, the Company closed on its underwritten public offering in which the Company granted the underwriter, EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), a 45-day option to purchase up to an additional 240,000 shares of Common Stock at the public offering price per share, less the underwriting discounts and commissions, to cover over-allotments, if any. These options were not exercised and expired. On June 20, 2023, we issued a 15% secured promissory note due to Al Dali International for Gen. Trading & Cont. Co., a company organized under the laws of Kuwait (“DIC”). As security to secure repayment of the Note, we issued DIC an option to purchase 1,000,000 shares of our common stock at an exercise price of $1.179 per share, which was recorded as a debt discount in the amount of $467,509, which is amortized to interest expense over the term of the agreement using the effective interest method. There were no other options granted during the nine months ended September 30, 2023 and 2022, respectively. The assumptions used in the Black-Scholes option pricing model to determine the fair value of the options on the date of issuance are as follows:
Schedule of assumptions |  |  |
|  | December 31, 2021 through September 30, 2023 |
Risk-free interest rate |  | 0.24 - 5.23% |
Expected dividend yield |  | None |
Expected life |  | 2.1 - 10 years |
Expected volatility rate |  | 142 - 273% |
The following table summarizes all stock option activity of the Company for the nine months ended September 30, 2023 and 2022:
Schedule of option activity |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (Years) |
Outstanding, December 31, 2022 |  |  | 1,833,566 |  |  | $ | 2.59 |  |  |  | 6.47 |
Granted |  |  | 1,000,000 |  |  |  | 1.18 |  |  |  | 1.75 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | (16,667 | ) |  |  | 12.00 |  |  |  | - |
Outstanding, September 30, 2023 |  |  | 2,816,899 |  |  | $ | 2.03 |  |  |  | 4.33 |
Outstanding, December 31, 2021 |  |  | 650,000 |  |  | $ | 12.00 |  |  |  | 7.53 |
Granted |  |  | 2,112,919 |  |  |  | 2.24 |  |  |  | 6.60 |
Exercised |  |  | (16,667 | ) |  |  | 11.1 |  |  |  | - |
Forfeited |  |  | (740,000 | ) |  |  | 10.00 |  |  |  | - |
Outstanding, September 30, 2022 |  |  | 2,006,252 |  |  | $ | 2.56 |  |  |  | 6.93 |
Exercisable, December 31, 2022 |  |  | 1,526,869 |  |  | $ | 2.65 |  |  |  | 5.94 |
Exercisable, September 30, 2023 |  |  | 2,671,883 |  |  | $ | 2.05 |  |  |  | 4.10 |
Exercisable, December 31, 2021 |  |  | 180,000 |  |  | $ | 12.00 |  |  |  | 7.01 |
Exercisable, September 30, 2022 |  |  | 1,175,059 |  |  | $ | 2.67 |  |  |  | 7.09 |
As of September 30, 2023 and 2022, the aggregate intrinsic value of the Company’s outstanding options was approximately none. The aggregate intrinsic value will change based on the fair market value of the Company’s common stock. Warrants As of September 30, 2023 and 2022, the Company had 80,000 warrants outstanding. On February 14, 2022, the Company closed on its underwritten public offering of 1,600,000 shares of common stock, at a public offering price of $5.00 per share. In addition, the Company has issued the underwriter, EF Hutton, a 5-year warrant to purchase 80,000 shares of common stock at an exercise price equal $5.75 and were valued with a fair market value of $374,000. The impact of these warrants has no effect on stockholder’s equity, as they are considered equity-like instruments, and are considered a direct expense of the offering.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration